Carters, Inc. (CRI) Tops Q2 EPS by 8c, Net Sales Rose 21% Y/Y
Tweet
Share
E-mailGet Alerts CRI Hot Sheet
Price: $38.70 -0.92%
Financial Fact:
Cost of goods sold: 525.88M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of goods sold: 525.88M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Carters, Inc. (NYSE: CRI) reported Q2 EPS of $0.22, $0.08 better than the analyst estimate of $0.14. Revenue for the quarter came in at $394.5 million versus the consensus estimate of $384.33 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
